Treatment of Constipation in Pregnancy
Start with dietary fiber (approximately 30 g/day) and adequate hydration, then escalate to polyethylene glycol or lactulose as first-line pharmacological therapy, while avoiding stimulant laxatives due to conflicting safety data. 1
Stepwise Treatment Algorithm
First-Line: Dietary and Lifestyle Modifications
- Increase dietary fiber to ~30 g/day through fruits, vegetables, whole grains, and legumes 1
- Ensure adequate fluid intake, particularly water, to soften stools 1
- Encourage patients to avoid straining during bowel movements by providing ample time and using relaxation techniques 1
The physiological basis for constipation in pregnancy is primarily elevated progesterone levels, which slow gastrointestinal motility. This affects 20-40% of pregnant women 1. The 2024 AGA Clinical Practice Update provides the most current evidence-based framework for management.
Second-Line: Bulk-Forming Agents
If dietary measures are insufficient:
- Psyllium husk or methylcellulose are safe due to lack of systemic absorption 1
- Psyllium (soluble fiber) is superior to insoluble fiber as it improves both stool viscosity and transit time, not just bulk 1
Third-Line: Osmotic Laxatives (Preferred Pharmacological Therapy)
Polyethylene glycol (PEG) or lactulose are both safe and effective first-line pharmacological options 1:
- PEG 4000 (10-17 g daily): Recent 2024 RCT data shows PEG and lactulose have similar efficacy for achieving complete spontaneous bowel movements (86.3% vs 82.9%), but PEG causes significantly less diarrhea and loose stools 2
- Lactulose (10-15 g daily): The only osmotic agent specifically studied in pregnancy 3, though it may cause more maternal bloating 1
Clinical Pearl: While both agents are effective, PEG may be preferable given the lower incidence of diarrhea and loose stools, which is particularly relevant in pregnancy 2, 4.
What to Avoid
Stimulant laxatives (bisacodyl, senna) should be avoided because safety data are conflicting 1. The 2024 AGA guideline explicitly states these should not be used as first-line therapy in pregnancy, despite their effectiveness in non-pregnant populations.
Common Pitfalls and Caveats
- Excessive fiber or osmotic laxatives can cause maternal bloating - titrate doses based on response 1
- Magnesium oxide: While effective in non-pregnant populations, use with caution in pregnancy and avoid in renal insufficiency 3
- Don't withhold treatment: The 2024 AGA emphasizes that interventions to optimize maternal health should not be withheld solely because a patient is pregnant 1
Associated Hemorrhoid Management
Since hemorrhoids occur in approximately 80% of pregnant women (especially third trimester), consider:
- Hydrocortisone foam is safe in the third trimester with no adverse events compared to placebo in a prospective study of 204 patients 1
Dose Titration Strategy
- Start with dietary modifications for 1-2 weeks
- Add bulk-forming agents if inadequate response
- Escalate to PEG (10-17 g daily) or lactulose (10-15 g daily)
- Titrate osmotic laxatives per symptom response and side effects - no clear maximum dose 1
- Monitor for bloating, cramping, or diarrhea and adjust accordingly